The actual benefit of subcutaneous (SC) HERCEPTIN is substantial.
Clinical Added Value
no clinical added value
The new subcutaneous formulation of HERCEPTIN is an addition to the range, complementing the intravenous formulation of HERCEPTIN that is currently available. Consequently, subcutaneous HERCEPTIN does not provide any improvement in actual benefit (level V, non-existent) compared with intravenous HERCEPTIN.
Listen
